PRQR logo

ProQR Therapeutics NV (PRQR) Long Term Debt

Annual Long Term Debt

$20.03 M
+$636.50 K+3.28%

December 31, 2023


Summary


Performance

PRQR Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRbalance sheetmetrics:

Quarterly Long Term Debt

$12.85 M
-$1.17 M-8.37%

September 1, 2024


Summary


Performance

PRQR Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

PRQR Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3.3%0.0%
3 y3 years-48.9%-31.1%
5 y5 years+86.6%-31.1%

PRQR Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-67.3%+3.3%-79.0%at low
5 y5-year-67.3%+40.7%-79.0%+133.1%
alltimeall time-67.3%>+9999.0%-79.0%+838.7%

ProQR Therapeutics NV Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$12.85 M(-8.4%)
Jun 2024
-
$14.02 M(-2.9%)
Mar 2024
-
$14.44 M(-27.9%)
Dec 2023
$20.03 M(+3.3%)
$20.03 M(+8.5%)
Sep 2023
-
$18.47 M(-1.6%)
Jun 2023
-
$18.77 M(-0.7%)
Mar 2023
-
$18.90 M(-2.5%)
Dec 2022
$19.39 M(-68.3%)
$19.39 M(+4.1%)
Sep 2022
-
$18.64 M(-65.9%)
Jun 2022
-
$54.67 M(-7.1%)
Mar 2022
-
$58.88 M(-3.8%)
Dec 2021
$61.22 M(+56.1%)
$61.22 M(+61.8%)
Sep 2021
-
$37.84 M(-2.0%)
Jun 2021
-
$38.60 M(+3.1%)
Mar 2021
-
$37.44 M(-4.5%)
Dec 2020
$39.21 M(+175.4%)
$39.21 M(+6.8%)
Sep 2020
-
$36.73 M(+566.6%)
Jun 2020
-
$5.51 M(-62.0%)
Mar 2020
-
$14.48 M(+1.7%)
Dec 2019
$14.24 M
$14.24 M(+23.8%)
Sep 2019
-
$11.50 M(-7.8%)
Jun 2019
-
$12.47 M(-0.1%)
DateAnnualQuarterly
Mar 2019
-
$12.48 M(+16.3%)
Dec 2018
$10.74 M(+69.4%)
$10.74 M(+46.1%)
Sep 2018
-
$7.35 M(+5.5%)
Jun 2018
-
$6.96 M(-1.4%)
Mar 2018
-
$7.06 M(+11.4%)
Dec 2017
$6.34 M(+5.3%)
$6.34 M(-17.0%)
Sep 2017
-
$7.64 M(+9.7%)
Jun 2017
-
$6.96 M(+11.5%)
Mar 2017
-
$6.24 M(+3.6%)
Dec 2016
$6.02 M(+14.2%)
$6.02 M(+48.1%)
Sep 2016
-
$4.07 M(-30.6%)
Jun 2016
-
$5.86 M(+0.5%)
Mar 2016
-
$5.83 M(+10.5%)
Dec 2015
$5.27 M(+53.3%)
$5.27 M(+8.2%)
Sep 2015
-
$4.88 M(+2.7%)
Jun 2015
-
$4.75 M(+51.6%)
Mar 2015
-
$3.13 M(-9.0%)
Dec 2014
$3.44 M(+151.4%)
$3.44 M(-2.9%)
Sep 2014
-
$3.54 M(-4.4%)
Jun 2014
-
$3.70 M(+170.7%)
Dec 2013
$1.37 M(+977.5%)
$1.37 M
Dec 2012
$127.00 K
-

FAQ

  • What is ProQR Therapeutics NV annual long term debt?
  • What is the all time high annual long term debt for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV annual long term debt year-on-year change?
  • What is ProQR Therapeutics NV quarterly long term debt?
  • What is the all time high quarterly long term debt for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV quarterly long term debt year-on-year change?

What is ProQR Therapeutics NV annual long term debt?

The current annual long term debt of PRQR is $20.03 M

What is the all time high annual long term debt for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high annual long term debt is $61.22 M

What is ProQR Therapeutics NV annual long term debt year-on-year change?

Over the past year, PRQR annual long term debt has changed by +$636.50 K (+3.28%)

What is ProQR Therapeutics NV quarterly long term debt?

The current quarterly long term debt of PRQR is $12.85 M

What is the all time high quarterly long term debt for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high quarterly long term debt is $61.22 M

What is ProQR Therapeutics NV quarterly long term debt year-on-year change?

Over the past year, PRQR quarterly long term debt has changed by $0.00 (0.00%)